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Virus entryTen years ago, the ﬁrst cellular receptor for the prototypic arenavirus lymphocytic choriomeningitis virus
(LCMV) and the highly pathogenic Lassa virus (LASV) was identiﬁed as α-dystroglycan (α-DG), a versatile
receptor for proteins of the extracellular matrix (ECM). Biochemical analysis of the interaction of α-DG with
arenaviruses and ECM proteins revealed a strikingly similar mechanism of receptor recognition that critically
depends on speciﬁc sugar modiﬁcation on α-DG involving a novel class of putative glycosyltransferase, the
LARGE proteins. Interestingly, recent genome-wide detection and characterization of positive selection in
human populations revealed evidence for positive selection of a locus within the LARGE gene in populations
from Western Africa, where LASV is endemic.
While most enveloped viruses that enter the host cell in a pH-dependent manner use clathrin-mediated
endocytosis, recent studies revealed that the Old World arenaviruses LCMV and LASV enter the host cell
predominantly via a novel and unusual endocytotic pathway independent of clathrin, caveolin, dynamin, and
actin. Upon internalization, the virus is rapidly delivered to endosomes via an unusual route of vesicular
trafﬁcking that is largely independent of the small GTPases Rab5 and Rab7. Since infection of cells with LCMV
and LASV depends on DG, this unusual endocytotic pathway could be related to normal cellular trafﬁcking of
the DG complex. Alternatively, engagement of arenavirus particles may target DG for an endocytotic pathway
not normally used in uninfected cells thereby inducing an entry route speciﬁcally tailored to the pathogen's
needs.© 2009 Elsevier Inc. All rights reserved.Arenaviruses are important human pathogens
The Arenaviridae represent a large group of viruses, which merit
signiﬁcant attention as tractablemodels for experimental virology and
as important human pathogens (Oldstone, 2002; Zinkernagel, 2002;
Buchmeier et al., 2007). Based on serologic and phylogenetic evidence,
arenaviruses are subdivided into two major groups, the Old World
arenaviruses found in Europe and Africa and the New World
arenaviruses endemic in the Americas (Clegg, 2002; Charrel et al.,
2008). Each arenavirus species has as natural reservoir one or a
limited number of closely related rodent species in which the virus is
maintained mainly as a persistent infection that is vertically
transmitted within the natural reservoir population. The present
phylogenetic diversity of arenaviruses is likely the result of long-term
co-evolution between viruses and their corresponding host species,
involving vertical and horizontal transfer of viruses within and
between populations, respectively (Charrel et al., 2001, 2002, 2003,
2008; Archer et al., 2002).virus; LASV, Lassa virus; DG,
ll rights reserved.While persistent infection of arenaviruses is usually asymptomatic
in the natural host, transmission to humans via contact with infected
rodents can cause severe disease (Geisbert and Jahrling, 2004). The
most signiﬁcant pathogen among the arenaviruses is the Old World
arenavirus Lassa virus (LASV) that causes a severe hemorrhagic fever
with high mortality in man. Endemic to West Africa from Senegal to
Cameroon, LASV causes several hundred thousand infections per year
with thousands of deaths (McCormick and Fisher-Hoch, 2002). The
problem is aggravated by the lack of a licensed vaccine and current
anti-arenavirus therapies being limited to the use of the nucleoside
analogue ribavirin (Rib), which is only partially effective and some-
times associated with side effects.
On the South American continent, Junin virus (JUNV), Machupo
(MACV), Guanarito (GTOV), and Sabia virus (SABV) have emerged as
causative agents of severe hemorrhagic fevers in Argentina, Bolivia,
Venezuela, and Brazil, respectively (Peters, 2002). Moreover, compel-
ling evidence indicates that the worldwide distributed LCMV is a
neglected human pathogen of clinical signiﬁcance, especially in cases
of congenital infection (Barton and Mets, 1999; Barton et al., 2002;
Jamieson et al., 2006). In addition, LCMV poses a special thread to
immuno-compromised individuals, as tragically illustrated by recent
cases of transplant-associated infections by LCMVwith fatal outcomes
(Fischer et al., 2006; Palacios et al., 2008). During the past years, seven
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human disease and more arenaviruses are likely to emerge in the
future (Charrel et al., 2008; Delgado et al., 2008).
Old World arenavirus receptor binding and virus–host cell
interaction
A detailed description of the structure, genome organization,
molecular biology, and cell biology of arenaviruses has been provided
by a number of excellent reviews (Buchmeier et al., 2007; Meyer et al.,
2002; Buchmeier, 2002, Lee and de la Torre, 2002) and I will focus
here selectively on aspects related to virus receptor binding and entry.
Attachment of a virus to its receptor molecules on the cell membrane
represents the ﬁrst step of every virus infection and is an important
determinant for the cellular tropism, host-range, and disease potential
of a virus. Receptor binding and subsequent cell entry of arenaviruses
are mediated by the envelope glycoprotein (GP). Initially synthesized
as a single polypeptide, the viral GP precursor (GPC) undergoes
proteolytic processing by the cellular proprotein convertase subtilisin
kexin isozyme-1/site-1 protease (SKI-1/S1P), yielding the mature
virion glycoproteins GP1 and GP2 (Lenz et al., 2001; Beyer et al., 2003;
Kunz et al., 2003; Rojek et al., 2008a). GP1 is located at the top of the
mature GP spikes that decorate the virion surface and interacts with
cell surface receptors (Borrow and Oldstone, 1992), whereas the
transmembrane GP2 shows similarities to the membrane proximal
fusion-active parts other viral envelope glycoproteins (Gallaher et al.,
2001; York et al., 2005; Eschli et al., 2006).
The ﬁrst cellular receptor for Old World arenaviruses was
identiﬁed as α-dystroglycan (α-DG), the peripheral moiety of DG, a
highly conserved and ubiquitously expressed cell surface receptor for
extracellular matrix (ECM) proteins (Cao et al., 1998). Initially
encoded as a single polypeptide, DG is cleaved into the extracellular
α-DG and membrane anchored β-DG (Barresi and Campbell, 2006).
DG is expressed in most cells of developing and adult tissues and
provides a molecular link between the ECM and the actin-based
cytoskeleton. Within the arenavirus family, α-DG is a primary
receptor for most isolates of LCMV, LASV, the related African
arenaviruses Mopeia (MOPV) and Mobala (MOBV), as well as the
Clade C New World arenaviruses Latino (LATV) and Oliveros (OLIV)
(Cao et al., 1998; Sevilla et al., 2000; Smelt et al., 2001; Spiropoulou et
al., 2002; Kunz et al., 2004, 2005a; Reignier et al., 2006). In the host
cell α-DG undergoes high-afﬁnity interactions with the ECM proteins
laminin, agrin, perlecan, and with neurexins. Alpha-DG is non-
covalently associated with β-DG, which binds intracellular to the
cytoskeletal adaptor proteins dystrophin and utrophin, that link the
DG complex to the actin cytoskeleton (Ervasti and Campbell, 1991,
1993). In many cell types, DG is found associated with additional
cellular proteins including α, β, γ, and δ-sacroglycans, and the
tetraspan protein sarcospan. These DG-associated proteins are crucial
for the stability and cellular trafﬁcking of the DG complex as
illustrated by genetic mutations that cause congenital neuromuscular
diseases in humans due to a loss of function of the receptor (Cohn,
2005; Barresi and Campbell, 2006, Kanagawa and Toda, 2006).
A remarkable feature of α-DG is its complex pattern of post-
translational modiﬁcations, including unusual sugar modiﬁcations,
which are crucial for binding to ECM proteins (Barresi and Campbell,
2006). In the ER, the DG precursor undergoes protein O-mannosyla-
tion, which is a rare protein modiﬁcation in mammalian cells and
involves the speciﬁc enzymes protein O-mannosyltransferase 1/2
(POMT1/2) and protein O-mannose β1,2-N-GlcNAc transferase 1
(POMGnT1). In the Golgi, α-DG is modiﬁed by the putative
glycosyltransferases LARGE and LARGE2 implicated in the synthesis
of an anionic sugar polymer of unknown structure that is crucial forα-
DG's binding to ECM proteins (Kanagawa et al., 2004). LARGE and
LARGE2 share a high degree of homology and their over-expression
results in similar hyperglycosylation ofα-DGwith increased binding toECM proteins (Brockington et al., 2005; Fujimura et al., 2005). While
LARGE is the dominant form expressed in brain and skeletal muscle,
both LARGE and LARGE2 are expressed in other tissues (Grewal et al.,
2005). Functional glycosylation of α-DG further involves the proteins
fukutin, and fukutin-related protein (FKRP) (Barresi and Campbell,
2006), whose functions are currently unknown.
The genes of the known and putative glycosyltransferases involved
in α-DG modiﬁcation are affected in human congenital neuromus-
cular diseases, so-called “secondary dystroglycanopathies”, that
manifest in a range of muscular and brain abnormalities caused by a
loss of function of DG as an ECM receptor (Cohn, 2005; Barresi and
Campbell, 2006; Kanagawa and Toda, 2006). Although the exact
glycosyltransferase activity of LARGE is currently unknown, several
lines of evidence strongly indicate that LARGE is involved in the
synthesis of sugar chains different from the O-mannosyl glycans
present on α-DG (Barresi et al., 2004; Kanagawa et al., 2004; Barresi
and Campbell, 2006). Enzymes that appear related to LARGE catalyze
modiﬁcations unrelated to O-mannosylation (Patnaik and Stanley,
2005). Further, over-expression of LARGE generates highly glycosy-
lated, functionalα-DG even in cells with defects in the biosynthesis of
the O-mannosyl sugar chains (Barresi et al., 2004; Patnaik and Stanley,
2005). Protein O-mannosylation and LARGE-dependent modiﬁcations
are also crucial for α-DG's function as a receptor for LASV, LCMV,
MOBV, MOPV, and Clade C New World arenaviruses (Imperiali et al.,
2005; Kunz et al., 2005b). Interestingly, over-expression of LARGE in
cells bearing a defect in protein O-mannosylation rescued arenavirus
infection (Rojek et al., 2007a), indicating that the LARGE-derived
sugars and not O-mannosyl glycans are the crucial structures
recognized by ECM proteins and arenaviruses.
In cells infected with Old World arenaviruses, expression of the
viral envelope GP late in the viral life cycle interferes speciﬁcally with
the functional glycosylation of α-DG, without affecting the biosynth-
esis of the DG core protein or other cell surface glycoproteins (Rojek et
al., 2007b). The viral GP targets the complex formed between the DG
precursor and LARGE in the Golgi, resulting in perturbation of LARGE-
dependent modiﬁcation of α-DG and down-regulation of the
functional receptor in infected cells (Rojek et al., 2007b). Considering
the crucial role of the LARGE-derived sugars for virus binding (Kunz et
al., 2005b; Rojek et al., 2007a) and the remarkably high receptor
binding afﬁnity of most Old World arenaviruses (Cao et al., 1998;
Sevilla et al., 2000; Kunz et al., 2001; Smelt et al., 2001; Kunz et al.,
2005a), down-regulation of glycosylated α-DG late in the life cycle
may be required to facilitate viral egress. The modulation of α-DG
glycosylation during arenavirus infection may thus be functionally
analogous to cleavage of cell surface sialic acid moieties by the virus-
encoded neuraminidase activities of ortho- and paramyxoviruses that
use glycans bearing terminal sialic acid as receptors (Palese and Shaw,
2007; Lamb and Parks, 2007).
The similarities in the recognition of α-DG-derived sugars by
arenaviruses and ECM proteins provide a striking example of how
pathogens mimic the molecular mechanisms of receptor recognition
by host-derived ligands. Considering their evolutionary conservation
and the crucial role of α-DG's glycans for the biological function of the
receptor, the ability of the virus to recognize these sugar structures
may have been advantageous during host–pathogen co-evolution. On
the other hand, it is conceivable that pathogenic arenaviruses like
LASV may have exerted selective pressure and may have inﬂuenced
the evolution of host genes associated with the remarkably complex
glycosylation of α-DG.
Like in all species, the human genome has been shaped by positive
natural selection for beneﬁcial traits, including resistance to infectious
diseases. The advent of genome-wide analysis of human genomic
variability provides unprecedented possibilities to identify human
genes under positive selection (Sabeti et al., 2006). A recent
groundbreaking study performed genome-wide detection and char-
acterization of positive selection in human populations by analyzing
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major ﬁndings, this study provided evidence for positive selection of
two genes that are functionally associated with the LASV receptor in a
Western African population from Yoruba, Nigeria, where over 20% of
the population show signs of pathogen exposure in some regions
(Richmond and Baglole, 2003). The strongest signal found in the
Yoruba population resided within a 400 kb region that lies entirely
within the LARGE gene that is implicated in functional glycosylation of
α-DG and another one associated with dystrophin (DMD), the
cytoskeletal adapter protein that links the DG complex to the actin
cytoskeleton. This evidence for positive selection of genes implicated
in the biological function of α-DG as a LASV receptor in a region of the
worldwhere LASV is endemic is remarkable and suggests a correlation
between the presence of the selected LARGE and dystrophin alleles
and resistance to disease. Follow-up studies including phenotypic
characterization are of high priority andwill allowamore quantitative
assessment of the impact of LASV on the human genome in affected
regions. Although reliable epidemiological data aremissing frommost
affected regions due to poor public health infrastructure and political
and social turmoil in the past decade, serological data revealed LASV
exposure of 8–52%, 4–55%, and 21% of the population in Sierra Leone,
Guinea, and some regions of Nigeria, respectively (Richmond and
Baglole, 2003).With currently close to 60million people at risk and an
annual incidence of disease of an estimated 3 million infectionsFig. 1. Old World arenaviruses use a novel pathway of endocytosis. The Old World arenavirus
actin-independent endocytotic pathway that delivers virus to endosomes bypassing the n
including the New World arenavirus Junin virus, enter cells by clathrin-mediated endocyto(McCormick and Fisher-Hoch, 2002), Lassa fever is arguably one of the
most neglected tropical diseases.
LCMV and LASV use a novel and unusual endocytotic pathway to
enter the host cell
Upon receptor binding, LCMV and LASV undergo endocytosis and
are delivered to acidiﬁed endosomes where the viral ribonucleopro-
tein enters the host cell's cytoplasmvia pH-dependent fusion between
the viral and the cellular membrane (Borrow and Oldstone, 1994). The
pH optimum for LCMV and LASV membrane fusion of b5.0 (Klewitz et
al., 2007) and pinpoints a late endosomal compartment as the site of
fusion and subsequent endosome-to-cytosol transport of the viral
nucleocapsid. Initial electron microscopic examination of LCMV entry
demonstrated uptake of virions in smooth vesicles lacking a clathrin
coat (Borrow and Oldstone, 1994). A more detailed characterization of
cell entry of LCMV and LASV conﬁrmed these early ﬁndings and
revealed that both viruses enter cells predominantly via an unusual
endocytotic pathway that shows some dependence on membrane
cholesterol (Shah et al., 2006: Vela et al., 2007; Rojek et al., 2008b),
but is independent of clathrin and caveolin, and does not require
dynamin, ARF6, ﬂotillin, or actin (Quirin et al., 2008; Rojek et al.,
2008b, 2008c) (Fig. 1). Receptor-mediated endocytosis of LCMV and
LASV occurred rapidly with pH-dependent fusion occurring after 16–es LCMV and LASV enter host cells via a cholesterol-dependent, clathrin-, caveolin, and
ormal incoming routes of endosomal trafﬁcking. In contrast, many enveloped viruses,
sis (for details see text).
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viral entry via clathrin-mediated endocytosis (Sieczkarski and Whit-
taker, 2003; Vonderheit and Helenius, 2005). Remarkably, endosomal
trafﬁcking of LCMV and LASV was only mildly affected by dominant
negative mutants of the small GTPase Rab5, involved in vesicular
trafﬁcking from the plasma membrane to the early endosome and
independent of Rab7 implicated in delivery from early to late
endosomes (Quirin et al., 2008; Rojek et al., 2008c). Consistent with
the independence of Rab5 and Rab7, co-localization studies revealed
that LCMV circumvents Rab5/EEA-1 positive early endosomes (Quirin
et al., 2008), indicating an unusual route of endosomal delivery.
The endocytotic pathway used by the Old World arenaviruses
LCMV and LASV are strikingly different from the pathways involved in
entry of most enveloped viruses, including the human pathogenic
New World arenaviruses that use human transferring receptor 1 as a
cellular receptor (Radoshitzky et al., 2007) and enter cells by clathrin-
mediated endocytosis (Martinez et al., 2007; Rojek et al., 2008b) (Fig.
1). Infection of cells by LASV and the LCMV isolates used, WE54
(Quirin et al., 2008) and clone-13 (Rojek et al., 2008b), critically
depend on cellular DG (Cao et al., 1998, Sevilla et al., 2000; Smelt et al.,
2001; Kunz et al., 2005a). The high binding afﬁnity of these viruses for
α-DG results in the formation of remarkably stable virus–receptor
complexes with negligible off-rates at neutral pH (Kunz et al., 2001;
Kunz et al., 2005a). Due to the virtually irreversible nature of the high-
afﬁnity binding between arenavirus GP and α-DG, virus binding is
likely followed by internalization of the virus–receptor complex. Since
arenaviruses mimic the molecular mechanism of receptor recognition
of α-DG's ECM ligands, binding of virus may trigger internalization of
DG by an endocytotic pathway that is part of the normal cellular
trafﬁcking of the receptor. Arenaviruses may thus serve as molecular
probes to investigate the largely unknown cellular trafﬁcking of the
DG complex. Considering the importance of DG and DG-associated
proteins for normal cell–ECM adhesion such studies may illuminate
novel aspects relevant for basic cell biology and human neuromus-
cular disease.
Alternatively, virus binding may target DG towards a route of entry
not normally used by the receptor. Precedent for a pathogen's ability
to “create” its own pathway of entry, tailored speciﬁcally to its needs,
has been provided by a series of landmark studies on the cell entry of
the anthrax toxin, the major virulence factor of Bacillus anthracis.
Intoxication of the host cell critically depends on the correct timing of
anthrax toxin endocytosis in order to allow correct assembly of the
toxin subunits prior to internalization (reviewed by Abrami et al.,
2005). The complex interaction between toxin and receptor involves
two counteracting pathogen-induced post-translational modiﬁcations
of the receptor, palmitoylation and ubiquitination, that ensures
targeting of the toxin-receptor complex for endocytosis only after
correct assembly has occurred (Abrami et al., 2003, 2004, 2006). In
analogy to the situationwith the anthrax toxin, engagement of cellular
α-DG by the multivalent arenavirus particles may cause receptor
clustering, inducing signaling and post-translational modiﬁcations of
DG and/or DG-associated proteins that do not normally occur in
uninfected cells. Such virus-induced receptor modiﬁcations may
target the DG complex towards a yet unknown clathrin-, caveolin-,
and dynamin-independent endocytotic route not normally used by
DG. Using the Old World arenaviruses as molecular probes, further
studies on cell entry may thus illuminate either the largely unknown
normal cellular trafﬁcking of DG and contribute to our knowledge of
this important receptor, or provide another example of an endocytotic
pathway “created” by a pathogen according to its speciﬁc require-
ments. Cellular proteins critical for entry the highly pathogenic LASV
may further represent promising new targets for the development of
anti-viral strategies against this important human pathogen. Investi-
gating the mechanisms of Old World arenavirus entry represents
therefore a perfect match between basic research in virus–host cell
interaction with an unmet biological problem that may pave the wayfor the development of new therapeutics to combat pathogenic
arenaviruses.
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